CORE CLINICAL SOLUTIONS LTD

Active London

Technical testing and analysis

Technical testing and analysisResearch and experimental development on biotechnology +1
C

CORE CLINICAL SOLUTIONS LTD

Technical testing and analysis

Founded 4 Mar 2025 Active London, United Kingdom website.com
Technical testing and analysisResearch and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
Accounts Due 4 Dec 2026 5 months remaining
Confirmation Submitted 17 Mar 2026 Next due 17 Mar 2027 9 months remaining
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

71-75 Shelton Street Covent Garden London WC2H 9JQ United Kingdom

Full company profile for CORE CLINICAL SOLUTIONS LTD (16291863), an active company based in London, United Kingdom. Incorporated 4 Mar 2025. Technical testing and analysis. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 March 2026
Due by 4 December 2026 5 months remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Justin Richard SlagelDirectorBritishUnited Kingdom554 Mar 2025Active
Roper, ChristopherDirectorBritishUnited Kingdom322 Oct 2025Active

Shareholders

Shareholders (1)

Christopher Roper
100.0%
75

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Mr Christopher Roper

British

Active
Notified 4 Mar 2025
Residence United Kingdom
DOB November 1993
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent

Mr Justin Richard Slagel

Ceased 17 Mar 2026

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Mar 2026OfficersChange to director Mr Christopher Roper on 19 Mar 2026
17 Mar 2026Confirmation StatementConfirmation statement made on 3 Mar 2026 with updates
17 Mar 2026Persons With Significant ControlCessation of Justin Richard Slagel as a person with significant control on 17 Mar 2026
17 Mar 2026Persons With Significant ControlChristopher Roper notified as a person with significant control
17 Mar 2026OfficersChange to director Mr Chris Roper on 17 Mar 2026
24 Mar 2026 Officers

Change to director Mr Christopher Roper on 19 Mar 2026

17 Mar 2026 Confirmation Statement

Confirmation statement made on 3 Mar 2026 with updates

17 Mar 2026 Persons With Significant Control

Cessation of Justin Richard Slagel as a person with significant control on 17 Mar 2026

17 Mar 2026 Persons With Significant Control

Christopher Roper notified as a person with significant control

17 Mar 2026 Officers

Change to director Mr Chris Roper on 17 Mar 2026

Recent Activity

Latest Activity

Change to director Mr Christopher Roper on 19 Mar 2026

2 months ago on 24 Mar 2026

Confirmation statement made on 3 Mar 2026 with updates

2 months ago on 17 Mar 2026

Cessation of Justin Richard Slagel as a person with significant control on 17 Mar 2026

2 months ago on 17 Mar 2026

Christopher Roper notified as a person with significant control

2 months ago on 17 Mar 2026

Change to director Mr Chris Roper on 17 Mar 2026

2 months ago on 17 Mar 2026